Abstract |
Malignant glucagonoma is an exceptional pancreatic endocrine tumour, with frequent dermatologic symptoms, diabetes and degradation of the general health status. Prognosis is unfavourable when liver metastases are present due to the usual inefficiency of chemotherapy. We report here an observation of a patient who was treated for a glucagonoma with multiple liver metastases, migratory necrolytic erythema, dilated cardiomypathy and diabetes that dramatically improved after a dacarbazin-based chemotherapy, allowing subsequent surgical resection of the primary. The patient was still alive and asymptomatic without progressive disease nearly two years after surgery.
|
Authors | L de Mestier, P Hammel, O Hentic, P Dove, P Lévy, P Ruszniewski |
Journal | Gastroenterologie clinique et biologique
(Gastroenterol Clin Biol)
Vol. 34
Issue 1
Pg. 106-10
(Jan 2010)
ISSN: 0399-8320 [Print] France |
Vernacular Title | Efficacité spectaculaire d'une chimiothérapie par 5-fluoro-uracile et dacarbazine chez un malade atteint de glucagonome métastatique avec insuffisance cardiaque. |
PMID | 19875259
(Publication Type: Case Reports, English Abstract, Journal Article)
|
Copyright | Copyright 2009. Published by Elsevier Masson SAS. |
Chemical References |
|
Topics |
- Adult
- Antineoplastic Combined Chemotherapy Protocols
(therapeutic use)
- Cardiomyopathy, Dilated
(complications)
- Dacarbazine
(administration & dosage)
- Female
- Fluorouracil
(administration & dosage)
- Glucagonoma
(drug therapy, pathology, surgery)
- Humans
- Liver Neoplasms
(drug therapy, secondary)
- Pancreatic Neoplasms
(pathology, surgery)
|